| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/13/2006 | EP1699792A1 Piperazine, 1,4¨diazepane, 1,4¨diazocane, and 1,5¨diazocane fused imidazo ring compounds |
| 09/13/2006 | EP1699471A1 Pharmaceutical active ingredient against hepatitis |
| 09/13/2006 | EP1699444A2 Means for inhibiting viral replication by regulation of protein folding |
| 09/13/2006 | EP1511752B1 Camptothecins with a modified lactone ring |
| 09/13/2006 | EP1497662B1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of sepsis |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1430060B1 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1385452B1 Ophthalmic drug delivery device |
| 09/13/2006 | EP1303295B1 Caseinoglycomacropeptide for inhibiting adhesion of the pathogenic flora of the skin |
| 09/13/2006 | EP1296997B1 Base analogues |
| 09/13/2006 | EP1284720B1 L-fmau for the treatment of hepatitis delta viral infection |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1280828B1 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1201236B1 Use of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for preventing or treating viral myocarditis |
| 09/13/2006 | EP1200067B1 Method for the preparation of microparticles comprising biological material |
| 09/13/2006 | EP1165126B1 Process for preparing a human papillomavirus vaccine with disassembled and reassembled virus-like particles |
| 09/13/2006 | EP1140158B1 Multi-component vaccine comprising at least two antigens from haemophilus influenzae |
| 09/13/2006 | EP1079807B1 Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract |
| 09/13/2006 | EP1077986B1 Improvements in macrolide production |
| 09/13/2006 | EP1064025B1 Combined vaccine compositions |
| 09/13/2006 | EP1054011B1 Novel antifungal compounds and process for producing the same |
| 09/13/2006 | EP0987957B1 Method for administering a viable microorganism composition to poultry |
| 09/13/2006 | CN1833022A Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequence and their therapeutic use |
| 09/13/2006 | CN1832960A Immunomodulating compositions, uses therefor and processes for their production |
| 09/13/2006 | CN1832930A Amide derivative |
| 09/13/2006 | CN1832921A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 09/13/2006 | CN1832920A Aryl and heteroaryl compounds, compositions, and methods of use |
| 09/13/2006 | CN1832755A Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections |
| 09/13/2006 | CN1832751A Periodontal disease therapeutic and/or preventive composition |
| 09/13/2006 | CN1832746A Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1831015A Process for extracting fructus ligustri lucidi and Radixa stragali polysaccharide, the products and application thereof |
| 09/13/2006 | CN1831009A Prawn white-spots syndrom virus (WSSV) membrane protein and its antibody |
| 09/13/2006 | CN1831004A Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy |
| 09/13/2006 | CN1830962A Derivatives of 2,6-dipyridylene cyclohexanone, and its application in preparing antibacterial medicine |
| 09/13/2006 | CN1830488A High density lipoprotein and its lipoprotein carrier used as anti coated virus medicine |
| 09/13/2006 | CN1830478A Medicine for treating syphilis |
| 09/13/2006 | CN1830476A Nanometer dragon's blood capsule and its preparation method |
| 09/13/2006 | CN1830462A Erycibes extraction, medicinal composition containing said oxtraction and its preparation method |
| 09/13/2006 | CN1830456A Preparation method of blood induction preparation for treating AIDS |
| 09/13/2006 | CN1830452A Preparation method of clindamycin hydrochloride freeze dried powder injection |
| 09/13/2006 | CN1830449A Medical use of flavine-3-beta galactoside and its preparation |
| 09/13/2006 | CN1830445A Tropane derivatives having therapy using, compounds and polymorph thereof |
| 09/13/2006 | CN1830444A Preparation method of Sophora flavescems injection |
| 09/13/2006 | CN1830443A Preparation method of sophora flavescens freeze dried powder injection |
| 09/13/2006 | CN1830441A Fluconazole gel for eye use |
| 09/13/2006 | CN1830440A Metronidazule injection and its preparation method and use |
| 09/13/2006 | CN1830439A Preparation method of metronidazole freeze dried powder injection |
| 09/13/2006 | CN1830424A Tebinaifen hydrochloride suppository and its preparation method |
| 09/13/2006 | CN1830423A Preparation method of garlicin injection |
| 09/13/2006 | CN1274823C Production of human interleukin 288 and recombined IL-288 engineering bacteria |
| 09/13/2006 | CN1274821C Modular transport systems for molecular substances and production and use thereof |
| 09/13/2006 | CN1274715C Memno peptides, a process for their preparation and their use |
| 09/13/2006 | CN1274707C Nucleotide specific for escherichia coli 0159 O-antigen |
| 09/13/2006 | CN1274706C Antisense nucleic acid with virus infection inhibiting function |
| 09/13/2006 | CN1274700C Nucleotide analogue composition |
| 09/13/2006 | CN1274688C Synthesis method of 5-hydroxy methyl furazolidone |
| 09/13/2006 | CN1274687C Suitqable to industrialized method for preparing emtricitabine |
| 09/13/2006 | CN1274686C Suitable industrialized method of preparing Lamivudine |
| 09/13/2006 | CN1274363C Auxiliary therapeutic agent for C type hepatitis |
| 09/13/2006 | CN1274362C Medicine for preventing and treating AIDS |
| 09/13/2006 | CN1274359C Capsule for treating AIDS and its production method |
| 09/13/2006 | CN1274356C Composite Chinese medicine for treating heptic fibrosis and cirrhosis due to hepatitis B and its mfg. method |
| 09/13/2006 | CN1274343C Preparation of medicine for treating herpes simplex keratitis |
| 09/13/2006 | CN1274331C Mixture for treating acute condyloma |
| 09/13/2006 | CN1274327C Nose drops agent for treating common cold and its preparation method |
| 09/13/2006 | CN1274325C Nose drop agent for treating common cold and its preparation method |
| 09/13/2006 | CN1274321C Astragalus injection Chinese medicinal preparation and its preparation method |
| 09/13/2006 | CN1274317C Remedies for dermatophytosis |
| 09/13/2006 | CN1274313C Preparation method of clindamycin phosphate powder injection |
| 09/13/2006 | CN1274312C Use of New Zealand vitexin-1 in preparing antiviral medicine |
| 09/13/2006 | CN1274309C Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 09/13/2006 | CN1274300C Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 09/13/2006 | CN1274297C Composition and drug form for curing oral nosomycosis |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105577 Antimicrobial method using a hydroxydiphenyl ether compound |
| 09/12/2006 | US7105575 Methods for the treatment of neuro- disorders using aminothiol compounds |
| 09/12/2006 | US7105574 Composition of GAP DMORIE and colipids; adjuvant of cytofectin and neutral lipid such as a phosphatidylethanolamine provide elevation of antibody levels particularly in applications where antibody levels from the immunogen-encoding polynucleotide alone are sub-optimal |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105554 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 09/12/2006 | US7105553 Thiazolyl amide derivatives |
| 09/12/2006 | US7105547 N-{3-[3-fluoro-4-(4-oxo-3,4-dihydro-2H-pyridin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide; treating gram-negative organisms such as Haemophilus influenza and Moraxella catarrhalis. |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105527 such as beta-D-N4-p-bromobenzoyl-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine; for treating human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections |
| 09/12/2006 | US7105522 Aids therapy; viricides |
| 09/12/2006 | US7105518 Thiopyrane-4-ones as DNA protein kinase inhibitors |
| 09/12/2006 | US7105510 dipyrido [1,4] diazepine derivatives; treating and preventing hiv |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105493 Methods and compositions for treating flaviviruses and pestiviruses |
| 09/12/2006 | US7105485 HO-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/12/2006 | US7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts |
| 09/12/2006 | US7105316 Neisseria lactoferrin binding protein |
| 09/12/2006 | US7105303 Antibodies to hepatitis C virus asialoglycoproteins |